Order Article Reprints

Jha NK, Sharma C, Meeran MFN, Jha SK, Dwivedi VD, Gupta PK, Dey A, Kesari KK, Ojha S. Cannabinoid Type-2 Receptor Agonist, JWH133 May Be a Possible Candidate for Targeting Infection, Inflammation, and Immunity in COVID-19. Immuno. 2021; 1(3):285-304. https://doi.org/10.3390/immuno1030020

Jha, Niraj Kumar, Charu Sharma, Mohamed Fizur Nagoor Meeran, Saurabh Kumar Jha, Vivek Dhar Dwivedi, Piyush Kumar Gupta, Abhijit Dey, Kavindra Kumar Kesari, and Shreesh Ojha. 2021. "Cannabinoid Type-2 Receptor Agonist, JWH133 May Be a Possible Candidate for Targeting Infection, Inflammation, and Immunity in COVID-19" Immuno 1, no. 3: 285-304. https://doi.org/10.3390/immuno1030020

Jha, N. K., Sharma, C., Meeran, M. F. N., Jha, S. K., Dwivedi, V. D., Gupta, P. K., Dey, A., Kesari, K. K., & Ojha, S. (2021). Cannabinoid Type-2 Receptor Agonist, JWH133 May Be a Possible Candidate for Targeting Infection, Inflammation, and Immunity in COVID-19. Immuno, 1(3), 285-304. https://doi.org/10.3390/immuno1030020